“Bowel Management Systems Market” in terms of revenue was estimated to be worth $2.19 billion in 2023 and is poised to reach $3.02 billion by 2031, growing at a CAGR of 4.24% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1422
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Bowel Management Systems market are:
- Favorable reimbursement policies
- Prevalence of chronic bowel disorders
- Increasing geriatric population
The following are the primary obstacles to the Bowel Management Systems market’s expansion:
- Underreporting of fecal incontinence (FI)
- A patient inclination for non-invasive clinical management of fecal incontinence (FI)
- Limited reimbursement coverage
Future expansion opportunities for the global Bowel Management Systems market include:
- Increasing home healthcare market
- Strategic collaborations by market players
- Rising awareness and acceptance of bowel-related disorders
Market Analysis:
The rising prevalence of chronic bowel disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and chronic constipation is increasing the market demand. Technological advancements in bowel management devices, including developing innovative and minimally invasive solutions, are also fueling market growth. Furthermore, the growing awareness among patients and healthcare providers, the emergence of home-based care solutions, and personalized treatment approaches present new growth opportunities for market players.
List of Prominent Players in the Bowel Management Systems Market:
- Coloplast Group
- ConvaTec Group, plc.
- Consure Medical
- Hollister Incorporated
- Laborie Medical Technologies, Corp.
- ProSys International Ltd.
- Renew Medical, Inc.
- Welland Medical Limited
- Qufora A/S
- Medtronic
- Wellspect HealthCare
- TG Eakin
Recent Developments:
- In April 2022, Microbiotica secured project funding from the Crohn’s and Colitis Foundation through their inflammatory bowel disease ventures program. This funding aims to support the development of therapies specifically designed to treat inflammatory bowel disease.
- In February 2022, Coloplast introduced the SenSura Mio in Singapore, aiming to enhance the quality of life for individuals with ostomies who are managing a stoma.
- In 2019, OstomyCure unveiled the TIES solution and initiated ongoing clinical trials at hospitals in the United Kingdom, Sweden, Poland, and Austria.
Bowel Management Systems Market Dynamics:
Market Drivers: Prevalence of Chronic Bowel Disorders
The prevalence of chronic bowel disorders varies geographically and is influenced by factors such as genetics, lifestyle, diet, and environmental factors. Conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and neurological disorders often require long-term management, creating a sustained demand for bowel management systems. These conditions substantially burden healthcare systems worldwide, leading to increased healthcare utilization, impaired quality of life, and economic costs.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1422
Challenges: Patient Inclination Towards Non-Invasive Clinical Management Of Fecal Incontinence (FI)
Patient inclination towards non-invasive clinical management of FI can pose challenges for the market for bowel management systems, particularly for invasive devices and surgical interventions. Companies operating in this space may need to address patient preferences, cost considerations, regulatory barriers, and educational needs to navigate and grow in this market segment effectively.
North America Is Expected To Grow With the Highest CAGR during the Forecast Period
The North American Bowel Management Systems Market is likely to register a significant revenue share and develop at a rapid CAGR soon. This is due to the growing population of older adults in this sector. It is anticipated that the U.S. will maintain its dominant position in the North American market throughout the forecast period. This prevalence is partly attributed to the higher incidence of irritable bowel syndrome (IBS) in this region. For instance, the International Foundation for Gastrointestinal Disorders estimates that between 25 and 45 million Americans are affected by IBS.
For More Customization @ https://www.insightaceanalytic.com/customisation/1422
Segmentation of Bowel Management Systems Market-
By Product-
- Systems
- Colostomy Bags
- Irrigation Systems
- Sacral Neuromodulation Systems
- Others
- Accessories
- Plugs
- Catheters
- Implants
- Anal Sphincters
- Stool Bags
- Others
By Patient Type-
- Pediatric
- Adult
By End-User-
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Care Settings
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Get More Information :
https://www.insightaceanalytic.com/report/bowel-management-systems-market/1422
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
